Trial intelligence / Profile preview

Dimemorfan phosphate granules for acute cough in children

CTR20132538Phase 3Completed

Sponsor
Shandong Bainuo Pharmaceutical
Start
Jul 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dimemorfan in cough, upper respiratory infection (URI), Acute pneumonia, acute bronchitis, pulmonary tuberculosis (TB), sponsored by Shandong Bainuo Pharmaceutical. Started Jul 2014; status: completed.

02

Drugs

dimemorfan
03

Conditions

coughupper respiratory infection (URI)Acute pneumoniaacute bronchitispulmonary tuberculosis (TB)

Beyond the preview

Go deeper on CTR20132538.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132538.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call